Videos

Rebecca Leach, MPH, BSN, RN, CIC: “[Compassion fatigue is] a hard topic for us because we’re not used to talking about this kind of thing in infection prevention. We’re very much focused on evidence-based care and standards. And so, this delves into a little bit of dealing with our emotions, right? And in health care, we don’t talk about that kind of thing.”

The CDC’s Runa Gokhale, MD, MPH: “I think that there is a role for infection preventionists to play here, and they are a community that we’ve been trying to engage through some of our sepsis awareness and sepsis prevention efforts.”

Kevin Kavanagh, MD: “I am convinced this virus is about one or two iterations away from completely avoiding the vaccine. And remember, we have the lambda variant and the kappa variant which are sitting out there in the wings, waiting for immunity to drop and possibly cause another wave.”

Ashish Mathur, PhD: “Today, there are no uniform industry standards to evaluate the efficacy of UVC devices. The onus is up to the infection preventionist to make sure and confirm that whatever claims have been made for the device are being substantiated by clinical evidence and third-party testing.”

Heather Saunders MPH, RN, CIC: “I think [infection preventionists] really need to be aware of what the efforts are at their state health departments and how they can collaborate with those efforts. IPs need to also have their own surveillance systems in place. They need to know what they’re looking for.”

Tania Bubb, PhD, RN, CIC: “I think there are many heroes to celebrate, but specifically, because we’re talking about infection preventionists, I want to highlight the work that they have done, and the positions that they had to manage and the flexibility and the agility that they had to exhibit during the pandemic.”

Karen Jones MPH, RN, CIC: “It’s really key to have a good written infection prevention and control plan at the hospital level but then also at the nursing home level. And what keeps that up to date? It’s an infection preventionist who’s knowledgeable, who’s been educated, who’s been trained, who’s certified.”

Kevin Kavanagh, MD: “India has the double mutation [COVID-19] variant. That’s the variant that has two escape mutations. And that is a variant we do not need to get into the United States and have it spread. Infection preventionists need to be out there beating the drum. First in their facility: They need to get everybody vaccinated.”

Luke Daum, PhD: “With regards to testing in the US, no other country compares to us. We do a great job in all 50 states of testing, having turnaround testing for using qPCR collection for at-home, or through the drive-through centers at CVS or Walgreens.”

Christina Yen, MD: “For any infection preventionists who are thinking about or are reviewing the need for VHP sometime in the future, just know that those colleagues that we’ve relied on this time around are going to be there and are going to be your partners in the VHP process.”

Michael L. Millenson: “The CDC will pay more attention to infections. But there’s also an asterisk here. Will Congress continue to pay attention to infections? Will the administration’s budget continue to pay attention to infections? Will the media continue to pay attention to infections?”